Financials
- Market Capitalization 1.99 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.02
Fiyat/satışlar oranı
0.98
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1987 | NUVB Nuvation Bio Inc. Class A Common Stock | 5.76 USD | -0.86% | +1.41% | +14.51% | +164.22% | 2.01 B USD | ||
| 1989 | ABCL AbCellera Biologics Inc. - Common Shares | 6.52 USD | -4.12% | -21.63% | +19.20% | +47.85% | 1.99 B USD | ||
| 1991 | SION Sionna Therapeutics, Inc. - Common Stock | 43.95 USD | -2.96% | +0.64% | +20.28% | +11.72% | 1.98 B USD | ||
| 2000 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.99 USD | -3.80% | -1.20% | +14.54% | -15.41% | 1.96 B USD |